Imagine a world where life-saving treatments are out of reach for those who need them most. This grim reality was once the norm for people living with HIV/AIDS, until trailblazers like Richard Jefferys stepped in to fight for change. On November 17, 2025, at 6:30 pm EST, Jefferys, the Basic Science, Vaccines and Cure Project director at the Treatment Action Group (TAG), will be honored with the 29th Annual Jonathan Lax Memorial Lecture at The Wistar Institute. His lecture, Community Advocacy and HIV Cure-Directed Research, will be livestreamed for a global audience, offering a rare opportunity to hear from a true changemaker. But here's where it gets even more inspiring: Jefferys’ journey began in the mid-90s, when he became a vocal advocate for health justice, fighting to expand access to medications, clinical trials, and services for those affected by HIV/AIDS. His work has spanned over three decades, focusing on increasing funding for research, raising awareness about clinical trials, and developing safer, more affordable treatments—all with the ultimate goal of finding a cure for HIV. And this is the part most people miss: Jefferys’ efforts have not only transformed lives in the U.S. but have also had a profound impact globally, particularly in the Global South, where access to care remains a critical challenge.
This year’s Wistar Legacy Awards will also honor two Philadelphians, Jay Kostman, M.D., and Robb Reichard, for their unwavering commitment to community advocacy. Dr. Kostman, chief medical officer at Philadelphia FIGHT, is being recognized for his 25+ years of contributions to Wistar’s HIV research program. Reichard, meanwhile, is celebrated for his leadership of the AIDS Fund, a nonprofit that provides vital support to vulnerable individuals living with AIDS in Philadelphia through grants, financial assistance, and educational initiatives.
Jefferys’ path to becoming a health justice icon began in 1994 at the AIDS Treatment Data Network in New York City, where he worked to simplify complex medical information and improve HIV care. In 1999, he played a pivotal role in the formation of the Health GAP Coalition, a global initiative aimed at ensuring access to life-saving medications for people with HIV worldwide. His upcoming lecture will reflect on these experiences, highlighting the progress made while emphasizing the work still ahead.
But here’s where it gets controversial: While Jefferys acknowledges the strides made in HIV research and treatment, he boldly asserts that the fight is far from over. “The late Jonathan Lax was a pioneering activist in the 80s, fighting stigma and isolation when many living with HIV/AIDS felt abandoned,” Jefferys notes. “His legacy inspires us, but we must continue pushing for innovative research, better health services, and equitable access to treatments—both in the U.S. and globally.” This statement raises a thought-provoking question: Are we doing enough to address the disparities in HIV care, or are systemic barriers still holding us back?
Luis J. Montaner, D.V.M., D.Phil., Wistar’s EVP and director of the HIV Cure and Viral Diseases Center, praises Jefferys’ impact: “Richard has redefined the HIV narrative, making science accessible and advocating for cure-directed research. His tireless efforts have paved the way for groundbreaking discoveries and clinical trials that could one day lead to an HIV cure.”
The Jonathan Lax Memorial Award Lecture, established after Lax’s death, has featured some of the most influential voices in HIV/AIDS research, including Nobel Laureates Drew Weissman and Françoise Barré-Sinoussi, as well as Anthony S. Fauci, former director of the National Institute of Allergy and Infectious Diseases. This year’s event continues this tradition, offering a platform for Jefferys to share his vision for the future of HIV advocacy and research.
The 2025 lecture is free and open to all. Here’s your chance to be part of the conversation: Register now at https://cvent.me/eAVqGP and join a global audience in honoring a true champion of health justice. But before you go, we want to hear from you: Do you think enough is being done to address HIV/AIDS globally, or are there still critical gaps that need to be addressed? Share your thoughts in the comments—let’s keep the dialogue going.
